Salipro Biotech is heading to PEGS Europe 2024, taking place in Barcelona (Spain), November 5-7!
Our Business Development Director, Peter Jahnmatz, will be there to present new exciting data from our latest collaborations on GPCR-targeted drug discovery.
If you are also attending, take the chance to meet Peter by his poster (B93) to exchange ideas on how the Salipro® platform can advance your drug discovery programs against complex membrane protein targets.
Let’s meet at PEGS and discuss exciting collaborations!
Salipro to join the upcoming PEGS Europe conference
Previous
Previous
Press Release: Salipro Biotech Expands Global Intellectual Property Portfolio with Granted Patents in Australia and Singapore
Next
Next